Specific findings from FDA inspections include failure to monitor cleanroom environments where sterile drugs are prepared, inadequate sterilization of equipment used in drug production, release of a batch of vitamin B6 despite microbial contamination detected in the production room, incomplete cleaning validation for equipment used in compounding implantable pellets, and repeat violations that were identified in previous inspections but not corrected
The question becomes how to pay for these molecules, the benefits they could have to health systems go far beyond anyone indication
Nausea, vomiting, or diarrhea
In the CNS, laminin deficiency leads to BBB breakdown, characterized by reduced pericyte coverage, leukocyte extravasation, and altered expressions of VE-cadherin, claudin-5, and occludin, underscoring laminin's role in maintaining BBB integrity [51, 66,67,68]